External validation of novel magnetic resonance imaging‐based models for prostate cancer prediction

医学 前列腺癌 接收机工作特性 磁共振成像 前列腺 核医学 放射科 癌症 内科学
作者
Lukas Püllen,Jan Philipp Radtke,Manuel Wiesenfarth,Monique J. Roobol,Jan Verbeek,Axel Wetter,Nika Guberina,Abhishek Pandey,Clemens Hüttenbrink,Stephan Tschirdewahn,Sascha Pahernik,Boris Hadaschik,Florian Distler
出处
期刊:BJUI [Wiley]
卷期号:125 (3): 407-416 被引量:26
标识
DOI:10.1111/bju.14958
摘要

Objectives To validate, in an external cohort, three novel risk models, including the recently updated European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator, that combine multiparametric magnetic resonance imaging (mpMRI) and clinical variables to predict clinically significant prostate cancer (PCa). Patients and Methods We retrospectively analysed 307 men who underwent mpMRI prior to transperineal ultrasound fusion biopsy between October 2015 and July 2018 at two German centres. mpMRI was rated by Prostate Imaging Reporting and Data System (PI‐RADS) v2.0 and clinically significant PCa was defined as International Society of Urological Pathology Gleason grade group ≥2. The prediction performance of the three models (MRI‐ERSPC‐3/4, and two risk models published by Radtke et al. and Distler et al., ModRad and ModDis) were compared using receiver‐operating characteristic (ROC) curve analyses, with area under the ROC curve (AUC), calibration curve analyses and decision curves used to assess net benefit. Results The AUCs of the three novel models (MRI‐ERSPC‐3/4, ModRad and ModDis) were 0.82, 0.85 and 0.83, respectively. Calibration curve analyses showed the best intercept for MRI‐ERSPC‐3 and ‐4 of 0.35 and 0.76. Net benefit analyses indicated clear benefit of the MRI‐ERSPC‐3/4 risk models compared with the other two validated models. The MRI‐ERSPC‐3/4 risk models demonstrated a discrimination benefit for a risk threshold of up to 15% for clinically significant PCa as compared to the other risk models. Conclusion In our external validation of three novel prostate cancer risk models, which incorporate mpMRI findings, a head‐to‐head comparison indicated that the MRI‐ERSPC‐3/4 risk model in particular could help to reduce unnecessary biopsies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
梵高的向日葵完成签到,获得积分10
1秒前
Ava的应助被宇智波小小怪采纳,获得10
1秒前
sagitar的应助被哈哈采纳,获得20
1秒前
俏皮夏菡发布了新的文献求助20
1秒前
123564举报苹果的求助涉嫌违规
2秒前
2秒前
坚强孤容发布了新的文献求助10
3秒前
3秒前
yang666完成签到,获得积分10
3秒前
5秒前
6秒前
7秒前
灰白发布了新的文献求助30
8秒前
9秒前
欣喜雨真完成签到,获得积分10
11秒前
xixi完成签到,获得积分10
12秒前
高瑛键完成签到,获得积分10
12秒前
聪明的行云完成签到 ,获得积分10
12秒前
cy发布了新的文献求助10
13秒前
Hello的应助被mooncake187采纳,获得10
13秒前
14秒前
14秒前
15秒前
NexusExplorer的应助被标致的秋荷采纳,获得10
16秒前
明理冷梅完成签到 ,获得积分10
16秒前
灰白完成签到,获得积分10
16秒前
追光完成签到,获得积分10
17秒前
一兰完成签到 ,获得积分10
17秒前
Dryad完成签到,获得积分10
18秒前
19秒前
霡霂发布了新的文献求助10
19秒前
渡花发布了新的文献求助30
20秒前
Shawn完成签到,获得积分10
20秒前
20秒前
冷傲路灯完成签到 ,获得积分10
22秒前
极HAO完成签到,获得积分10
22秒前
小情绪发布了新的文献求助10
23秒前
山外方有山完成签到,获得积分10
23秒前
阿王不理你完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611